PT3157918T - Derivados de 2-aril-4-hidroxi-1,3-tiazole úteis como inibidores de trpm8 no tratamento de neuralgia, dor, dpoc e asma - Google Patents
Derivados de 2-aril-4-hidroxi-1,3-tiazole úteis como inibidores de trpm8 no tratamento de neuralgia, dor, dpoc e asmaInfo
- Publication number
- PT3157918T PT3157918T PT15730801T PT15730801T PT3157918T PT 3157918 T PT3157918 T PT 3157918T PT 15730801 T PT15730801 T PT 15730801T PT 15730801 T PT15730801 T PT 15730801T PT 3157918 T PT3157918 T PT 3157918T
- Authority
- PT
- Portugal
- Prior art keywords
- trpm8
- neuralgia
- copd
- asthma
- pain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/42—One oxygen atom attached in position 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14173502 | 2014-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3157918T true PT3157918T (pt) | 2019-05-09 |
Family
ID=50979632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT15730801T PT3157918T (pt) | 2014-06-23 | 2015-06-23 | Derivados de 2-aril-4-hidroxi-1,3-tiazole úteis como inibidores de trpm8 no tratamento de neuralgia, dor, dpoc e asma |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US10196368B2 (pt) |
| EP (1) | EP3157918B1 (pt) |
| JP (1) | JP6557332B2 (pt) |
| KR (1) | KR102493005B1 (pt) |
| CN (1) | CN106660975B (pt) |
| AU (1) | AU2015279272B2 (pt) |
| CY (1) | CY1121624T1 (pt) |
| DK (1) | DK3157918T3 (pt) |
| EA (1) | EA034525B1 (pt) |
| ES (1) | ES2724111T3 (pt) |
| HR (1) | HRP20190819T1 (pt) |
| HU (1) | HUE043586T2 (pt) |
| LT (1) | LT3157918T (pt) |
| MA (1) | MA39912B1 (pt) |
| ME (1) | ME03399B (pt) |
| PL (1) | PL3157918T3 (pt) |
| PT (1) | PT3157918T (pt) |
| RS (1) | RS58590B1 (pt) |
| SI (1) | SI3157918T1 (pt) |
| TR (1) | TR201905319T4 (pt) |
| WO (1) | WO2015197640A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3184524A1 (en) * | 2015-12-21 | 2017-06-28 | Dompé farmaceutici S.p.A. | 4-hydroxy-2-phenyl-1,3-thiazol-5-yl methanone derivatives as trpm8 antagonists |
| EP3409277A1 (en) * | 2017-05-30 | 2018-12-05 | Dompé farmaceutici s.p.a. | Il-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections |
| EP3782702A1 (en) * | 2019-08-21 | 2021-02-24 | AC BioScience SA | Compounds and use thereof for the treatment of infectious diseases and cancer |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE122008000051I1 (de) * | 1990-11-30 | 2009-02-05 | Teijin Ltd | 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel |
| JP2008515950A (ja) | 2004-10-13 | 2008-05-15 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 泌尿器系障害の処置用の冷メントール受容体−１（ｃｍｒ−１）アンタゴニストとしての４−置換ベンジルオキシ−フェニルメチルアミド誘導体 |
| WO2007017092A1 (en) | 2005-08-04 | 2007-02-15 | Bayer Healthcare Ag | Substituted 4-benzyloxy-benzoic acid amide derivatives |
| WO2007017093A1 (en) | 2005-08-04 | 2007-02-15 | Bayer Healthcare Ag | Substituted 2-benzyloxy-benzoic acid amide derivatives |
| WO2007017094A1 (en) | 2005-08-04 | 2007-02-15 | Bayer Healthcare Ag | Substituted benzyloxy-phenylmethylcarbamate derivatives |
| WO2007080109A1 (en) | 2006-01-16 | 2007-07-19 | Bayer Healthcare Ag | Substituded benzyloxy-phenylmethylurea derivatives |
| WO2007134107A2 (en) | 2006-05-10 | 2007-11-22 | Janssen Pharmaceutica N.V. | Cold menthol receptor-1 antagonists |
| US8153682B2 (en) | 2007-07-18 | 2012-04-10 | Janssen Pharmaceutica, Nv | Sulfonamides as TRPM8 modulators |
| WO2010103381A1 (en) | 2009-03-13 | 2010-09-16 | Glenmark Pharmaceuticals S.A. | Spirocyclic piperidine derivatives as trpm 8 modulators |
| EP2424517A4 (en) | 2009-05-01 | 2013-01-23 | Raqualia Pharma Inc | SULFAMOYLBENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS |
| WO2013092711A1 (en) * | 2011-12-19 | 2013-06-27 | Dompe' S.P.A. | Trpm8 antagonists |
| EP2606888A1 (en) * | 2011-12-19 | 2013-06-26 | Dompe' S.P.A. | Trpm8 antagonists |
-
2015
- 2015-06-23 ES ES15730801T patent/ES2724111T3/es active Active
- 2015-06-23 EP EP15730801.6A patent/EP3157918B1/en active Active
- 2015-06-23 TR TR2019/05319T patent/TR201905319T4/tr unknown
- 2015-06-23 ME MEP-2019-110A patent/ME03399B/me unknown
- 2015-06-23 US US15/321,364 patent/US10196368B2/en active Active
- 2015-06-23 PT PT15730801T patent/PT3157918T/pt unknown
- 2015-06-23 CN CN201580030277.1A patent/CN106660975B/zh active Active
- 2015-06-23 EA EA201790072A patent/EA034525B1/ru unknown
- 2015-06-23 HU HUE15730801A patent/HUE043586T2/hu unknown
- 2015-06-23 JP JP2017519806A patent/JP6557332B2/ja active Active
- 2015-06-23 AU AU2015279272A patent/AU2015279272B2/en active Active
- 2015-06-23 PL PL15730801T patent/PL3157918T3/pl unknown
- 2015-06-23 MA MA39912A patent/MA39912B1/fr unknown
- 2015-06-23 LT LTEP15730801.6T patent/LT3157918T/lt unknown
- 2015-06-23 SI SI201530723T patent/SI3157918T1/sl unknown
- 2015-06-23 WO PCT/EP2015/064146 patent/WO2015197640A1/en active Application Filing
- 2015-06-23 RS RS20190461A patent/RS58590B1/sr unknown
- 2015-06-23 KR KR1020167035368A patent/KR102493005B1/ko active IP Right Grant
- 2015-06-23 DK DK15730801.6T patent/DK3157918T3/da active
-
2018
- 2018-12-06 US US16/211,722 patent/US11046662B2/en active Active
-
2019
- 2019-05-02 HR HRP20190819TT patent/HRP20190819T1/hr unknown
- 2019-05-10 CY CY20191100508T patent/CY1121624T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20190106395A1 (en) | 2019-04-11 |
| LT3157918T (lt) | 2019-05-27 |
| US10196368B2 (en) | 2019-02-05 |
| MA39912B1 (fr) | 2019-05-31 |
| HUE043586T2 (hu) | 2019-08-28 |
| EA034525B1 (ru) | 2020-02-17 |
| EA201790072A1 (ru) | 2017-11-30 |
| MA39912A (fr) | 2017-04-26 |
| HRP20190819T1 (hr) | 2019-06-28 |
| DK3157918T3 (da) | 2019-05-13 |
| ES2724111T3 (es) | 2019-09-06 |
| EP3157918B1 (en) | 2019-03-27 |
| US11046662B2 (en) | 2021-06-29 |
| JP6557332B2 (ja) | 2019-08-07 |
| CN106660975B (zh) | 2019-12-31 |
| CN106660975A (zh) | 2017-05-10 |
| KR102493005B1 (ko) | 2023-01-30 |
| ME03399B (me) | 2020-01-20 |
| US20170190678A1 (en) | 2017-07-06 |
| JP2017520623A (ja) | 2017-07-27 |
| CY1121624T1 (el) | 2020-07-31 |
| PL3157918T3 (pl) | 2019-08-30 |
| EP3157918A1 (en) | 2017-04-26 |
| AU2015279272B2 (en) | 2018-01-18 |
| AU2015279272A2 (en) | 2017-01-19 |
| TR201905319T4 (tr) | 2019-05-21 |
| AU2015279272A1 (en) | 2017-01-12 |
| RS58590B1 (sr) | 2019-05-31 |
| KR20170031664A (ko) | 2017-03-21 |
| SI3157918T1 (sl) | 2019-05-31 |
| WO2015197640A1 (en) | 2015-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272820B (en) | The history of sulfamoylpyrrolamide and their use as drugs to treat jaundice b | |
| HK1257955A1 (zh) | 用於治療肌聯蛋白類肌病和其他肌聯蛋白病變的材料和方法 | |
| HK1256380A1 (zh) | 修飾的細胞和治療方法 | |
| IL250415B (en) | Antibodies against pd-l and methods of using them | |
| SG11201706766WA (en) | Materials and methods for treatment of hemoglobinopathies | |
| SG10202002593SA (en) | Activated bifidobacteria and methods of use thereof | |
| PL3160498T3 (pl) | Cząsteczki na bazie IL-15 i sposoby ich zastosowania | |
| EP2968298A4 (en) | 2,4-THIAZOLIDINEDIONES ENRICHED IN DEUTERIUM AND METHODS OF TREATMENT | |
| GB201404470D0 (en) | Therapeutic methods and materials | |
| EP3133919A4 (en) | Agents and methods for treatment of pathogens | |
| EP3134108A4 (en) | Agents and methods of treatment | |
| SG11201605915WA (en) | Furo-3-carboxamide derivatives and methods of use | |
| GB201511799D0 (en) | Composition and methods of treatment | |
| EP3151821A4 (en) | Marmelin analogs and methods of use in cancer treatment | |
| PL3128838T3 (pl) | Stymulatory roślin, ich zastosowanie i sposób stymulacji roślin | |
| ME03399B (me) | DERIVATI 2-ARIL-4-HIDROKSI-1,3-TIAZOLA KORISNI KAO INHIBITORI TRPM8 U LEĆENJU NEURALGIJE, BOLA, COPD l ASTME | |
| IL251840A0 (en) | Use of femiroplast in the treatment of severe asthma | |
| HK1255728A1 (zh) | 利用抗il-23a抗體的哮喘治療 | |
| GB201417248D0 (en) | Compostion and methods of treatment | |
| ZA201802201B (en) | Novel formulation and treatment methods | |
| ZA201408464B (en) | Composition for the use in treatment of asthma | |
| AU2014901480A0 (en) | Agents and methods of treatment | |
| GB201416797D0 (en) | Contianer and method of use thereof | |
| SG10201400823PA (en) | Therapeutic methods and compositions for treating diabetes | |
| GB201404610D0 (en) | Preparation and method for the treatment of skin |